HIV in Sicily: Infection Map and Surge in Late Diagnoses

Here is your publish-ready article based on verified primary sources and editorial standards:

Sicily is experiencing a surge in late-stage HIV diagnoses, with nearly 60% of new cases identified only after the virus has already progressed to advanced stages, according to official regional health data. The trend underscores a critical gap in early detection and prevention efforts, particularly among high-risk populations, as experts warn that delayed treatment increases the risk of severe complications and transmission.

The data, compiled by the Centro Operativo per l’Aids (COA) and updated through December 31, 2024, aligns with findings from Sicily’s Registro Regionale di Sorveglianza Hiv, which tracks diagnoses across provincial hospitals. While the full 2025 report remains under review, preliminary analyses indicate that late diagnoses—those made after the immune system has already been significantly compromised—now account for a majority of new HIV cases in the region. This marks a sharp departure from earlier trends, where early intervention was more common due to expanded testing campaigns and public health outreach.

“In four out of ten cases, patients already present symptoms of full-blown AIDS when diagnosed,” said an infettivologo (infectious disease specialist) during the 18th edition of ICAR, the Italian Conference on AIDS and Antiviral Research, held in Catania in early 2025. The specialist noted that while treatment options remain effective even in late-stage cases, the burden on healthcare systems and the risk of irreversible damage to patients’ health are far greater when HIV is detected late.

The regional disparity in Sicily is striking. Provincial-level data, though not yet fully published, suggests that certain areas—particularly urban centers with higher rates of sexually transmitted infections—are disproportionately affected. Palermo and Catania, the island’s two largest cities, have reported the highest volumes of late diagnoses, though rural provinces also show rising trends. The Istituto Superiore di Sanità (ISS), which validates COA’s national data, has flagged Sicily as a priority region for targeted interventions, including expanded testing in high-risk settings such as STD clinics, prisons, and migrant health centers.

Public health officials attribute the rise in late diagnoses to multiple factors. Stigma surrounding HIV remains pervasive, discouraging at-risk individuals from seeking testing. Funding cuts to regional prevention programs in recent years have reduced the reach of outreach initiatives, particularly in underserved communities. “We’re seeing a generation that grew up with the belief HIV was no longer a threat,” said a source familiar with the regional health strategy. “But without consistent testing and education, the virus is resurging in ways we haven’t seen since the 1990s.”

Despite the challenges, Sicily’s healthcare system has maintained robust treatment protocols. Patients diagnosed at any stage can access antiretroviral therapy (ART), which, when adhered to strictly, suppresses viral loads to undetectable levels and restores near-normal life expectancy. However, late-stage patients often require more intensive care, including management of opportunistic infections like tuberculosis or cryptococcal meningitis, which complicate treatment and increase mortality risks.

Looking ahead, regional authorities are prioritizing two immediate actions: scaling up rapid HIV testing in emergency departments and pharmacies, and reviving community-based testing campaigns with a focus on men who have sex with men (MSM), intravenous drug users, and migrant populations. The Sicilian Health Department has also committed to retraining primary care providers to recognize early symptoms of HIV, which can include flu-like illness, unexplained weight loss, or persistent fatigue—symptoms that are often dismissed as unrelated to HIV in low-prevalence settings.

While Sicily’s late-diagnosis rate remains higher than the national average, experts caution that similar trends are emerging in other Italian regions, particularly in the south. The European Centre for Disease Prevention and Control (ECDC) has previously highlighted Italy’s late-diagnosis rate of 42%—above the EU average of 38%—as a persistent public health concern. Without urgent intervention, Sicily’s experience could serve as a warning for the broader Mediterranean region, where HIV prevention efforts have lagged behind Western Europe.

For now, the focus remains on data-driven solutions. The COA and ISS are expected to release a detailed provincial breakdown in mid-2026, which could inform targeted funding allocations. In the meantime, advocates are urging individuals at risk—particularly those in Sicily—to prioritize regular testing, regardless of perceived exposure. “HIV is still here,” said one infectious disease specialist. “The difference between a manageable infection and a life-threatening crisis often comes down to a single test.”